We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SDGR market cap is 1.66B. The company's latest EPS is USD 0.5631 and P/E is 40.69.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 64.78M | 35.19M | 42.57M | 74.13M | 36.6M |
Operating Income | 116.82M | -61.13M | -56.19M | -29.73M | -67.43M |
Net Income | 129.14M | 4.28M | -62.02M | -30.67M | -54.72M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 85.54M | 108.1M | 137.93M | 180.96M | 216.67M |
Operating Income | -37.77M | -56.81M | -113.22M | -134.99M | -30.24M |
Net Income | -24.57M | -24.46M | -100.39M | -149.19M | 40.72M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 838.77M | 841.57M | 794.15M | 802.96M | 737.76M |
Total Liabilities | 248.51M | 230.34M | 230.57M | 254.4M | 224.06M |
Total Equity | 590.26M | 611.23M | 563.58M | 548.56M | 513.71M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 155.27M | 746.26M | 756.49M | 688.59M | 802.96M |
Total Liabilities | 57.01M | 122.24M | 199.4M | 240.68M | 254.4M |
Total Equity | -93.32M | 624.02M | 557.09M | 447.91M | 548.56M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -31.09M | -49.54M | -99.48M | -136.73M | -39.28M |
Investing | 172.2M | 239.45M | 252.65M | 193.03M | 5.08M |
Financing | 867k | 5.39M | 6.72M | 9.05M | 8.01M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -26.06M | 16.76M | -70.67M | -119.68M | -136.73M |
Investing | -53.86M | -381.72M | -16.81M | 90.02M | 193.03M |
Financing | 28.68M | 541.27M | 7.95M | 2.11M | 9.05M |
Market Cap | 1.66B |
Price to Earnings Ratio | 40.69 |
Price to Sales Ratio | 7.65 |
Price to Cash Ratio | 10.67 |
Price to Book Ratio | 3.02 |
Dividend Yield | - |
Shares Outstanding | 72.31M |
Average Volume (1 week) | 743.42k |
Average Volume (1 Month) | 836.85k |
52 Week Change | -16.79% |
52 Week High | 59.24 |
52 Week Low | 20.76 |
Spread (Intraday) | 0.23 (0.99%) |
Company Name | Schrodinger Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.schrodinger.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions